Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4

Ovarian cancer (OC) is the most lethal gynaecologic malignancy, attributed to its insidious growth, non-specific symptoms and late presentation. Unfortunately, current screening modalities are inadequate at detecting OC and many lack the appropriate specificity and sensitivity that is desired from a...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Therapeutic Advances in Medical Oncology
المؤلفون الرئيسيون: Aruni Ghose, Lucy McCann, Shania Makker, Uma Mukherjee, Sri Vidya Niharika Gullapalli, Jayaraj Erekkath, Stephanie Shih, Ishika Mahajan, Elisabet Sanchez, Mario Uccello, Michele Moschetta, Sola Adeleke, Stergios Boussios
التنسيق: مقال
اللغة:الإنجليزية
منشور في: SAGE Publishing 2024-02-01
الوصول للمادة أونلاين:https://doi.org/10.1177/17588359241233225